Agents of Care

Author(s):  
Melanie Armstrong

Following 9/11 and the subsequent anthrax attacks, the U.S. government enlisted the public health industry in homeland security and defense, bringing weapons like disease surveillance and life science research to the war against terrorism. As Congress poured out funding for bioterrorism preparedness, agencies like the Centers for Disease Control and Prevention rearranged themselves around new logics of biosecurity. In the decade after 9/11, CDC brought its surveillance, science, and communication practices to bear on questions of national security, and became a federal organizing agency for emergency response and pharmaceutical stockpile stewardship. The political transformations at the CDC exemplify how bioterrorism changed the role of government in disease management, along with the specific work of the nation’s largest public health agency.

2019 ◽  
Vol 11 (1) ◽  
Author(s):  
Peter Hicks

Colleagues,I am delighted to present to you the summary abstracts and presentations from the 2019 International Society of Disease Surveillance (ISDS) Conference which was held San Diego, CA from January 30th – February 2nd, 2019.  Over the past several years, the concept of investing in data science and data scientists has been touted as a transformational endeavor for governmental organizations, non-profits, as well as private sector and commercial markets. How “true” data science is harnessed to influence and improve public health surveillance and population health remains to be seen. Data science has great potential to provide a new lens to inform and improve public health surveillance and population health. However, this lens needs to focus upon more than just “Big Data” analytics and information technology. It must also focus on fostering organizational environments and multi-agency collaborations that invigorate curiosity and experimentation and development of cross-disciplinarian partnerships to address multifactorial and multidimensional health and disparity challenges. It also must hone in on producing evidence-based analytic results to improve measurable health outcomes. Analysis and summary results are not the end products for surveillance. The concept of data science needs to be leveraged across public health to better communicate the findings of disease surveillance through the “storytelling of illness and disease” to influence public health policy, and ultimately improve population health.This year, with these ideas in mind, and with the support of a dynamic, engaged, and multi-disciplinary Scientific Planning Committee (SPC) - ISDS has expanded its conference scope beyond traditional tracks which historically focused on surveillance, informatics, and analysis, to include tracks related to:One HealthNon – Human Health SurveillanceEcologyCommunications, Medical Rhetoric, Visualization, and ReportingChronic Disease / Mental HealthSubstance AbuseData QualityInjury SurveillanceSubstance Abuse – Opioid SurveillanceRecognizing that Public Health is a collaborative and multi-disciplinary team sport, we have expanded our outreach efforts to include new partners across academia, the private sector, state, local, and tribal partners, as well as federal agencies.  During the 2019 ISDS Conference, we had a significant increase in overall attendance (~375) and abstracts submissions compared to prior years; with 29 countries represented and 130 oral presentations and 95 poster presentations provided over the three-day conference.   We held a number of sessions on Opioid Use and Prescribing Surveillance as well as Medical Rhetoric, Communications, and Visualization that were standing-room only and beyond.Our keynote speakers on the intersection of Data Science and Public Health included: William J. Kassler, MD, MPH, IBM Watson Health – Deputy Chief Health OfficerWilma J. Wooten, MD, MPH, Public Health Officer for the County of San DiegoMichael Hogarth, MD, FACP, FACMI, Chief Clinical Research Information Officer for University of California San Diego HealthSome of the key take-aways from the presentations at the 2019 ISDS Conference were that data science and the act of data collections and analysis are NOT the end goals of public health surveillance; they are just the beginning.  Data do NOT speak for themselves; they require context, curation, interpretation, and ultimately need to effectively communicating findings through the story telling of illness and disease to officials, policy makers, and the public with the objective to inform and influence public health policy, motivate health behavior change, drive public health action, and ultimately improve population health.I encourage you to review the abstracts submitted here in the Online Journal of Public Health Informatics which were presented at the 2019 International Society for Disease Surveillance 2019 Conference and to engage multi-dimensional and multi-disciplinary conversations (reach out directly to authors and presenters) around these important topics, expand your networks and opportunities in the public health community. Regards,Peter Hicks, MA, MPHScientific Program Chair International Society for Disease Surveillance (ISDS) 2019Centers for Disease Control and Prevention**Information included in this statement are those of the author and do not represent the official position of the Centers for Disease Control and Prevention (CDC)


Author(s):  
Sarah Palmeter

In the completion of my practicum at the Public Health Agency of Canada (PHAC) this summer, I worked to develop a surveillance knowledge product to support the national surveillance of developmental disorders. This project used Statistics Canada’s 2017 Canadian Survey on Disability to investigate the burden of developmental disorders in Canada. Developmental disorders are conditions with onset in the developmental period. They are associated with developmental deficits and impairments of personal, social, academic, and occupational function. The project objectives are to estimate the prevalence of developmental disorders in Canadians 15 years of age or older, overall and by age and sex, as well as report on the age of diagnosis, disability severity, and disability co-occurrence in those with developmental disorders. The majority of the analysis has been completed and preliminary results completed, which cannot be released prior to PHAC publication. Although not highly prevalent, developmental disorders are associated with a high level of disability in young Canadians. Early detection and interventions have been shown to improve health and social outcomes among affected individuals. Understanding the burden of developmental disorders in Canada is essential to the development of public health policies and services.


Author(s):  
Joshua M. Sharfstein

Firefighters fight fires. Police officers race to crime scenes, sirens blaring. And health officials? Health officials respond to crises. There are infectious disease crises, budget crises, environmental health crises, human resources crises—and many more. At such critical moments, what happens next really matters. A strong response can generate greater credibility and authority for a health agency and its leadership, while a bungled response can lead to humiliation and even resignation. Health officials must be able to manage and communicate effectively as emotions run high, communities become engaged, politicians lean in, and journalists circle. In popular imagination, leaders intuitively rise to the challenge of a crisis: Either they have what it takes or they do not. In fact, preparation is invaluable, and critical skills can be learned and practiced. Students and health officials alike can prepare not only to avoid catastrophe during crises, but to take advantage of new opportunities for health improvement. The Public Health Crisis Survival Guide provides historical perspective, managerial insight, and strategic guidance to help health officials at all levels not just survive but thrive in the most challenging of times.


2021 ◽  
Author(s):  
Saketh Sundar ◽  

Throughout the COVID-19 pandemic, headlines ranging from “Coronavirus forecasts are grim: It’s going to get worse” to “Covid-19 cases and deaths in the US will fall over the next four weeks, forecast predicts” have dominated the news (Achenbach, 2020; Kallingal, 2021). The weekly-published Center for Disease Control and Prevention (CDC) COVID-19 forecasts have become the go-to forecasts for the media, the public, and various levels of government (Cramer et al., 2021). These projections, generated from epidemiological forecasting, not only inform the public’s caution towards the pandemic but are also crucial for officials to create public health guidelines and allocate resources in hospitals (Gibson et al., 2020). But where do these predictions come from?


Author(s):  
Maria E. Fernandez ◽  
Patricia Dolan Mullen ◽  
Jennifer Leeman ◽  
Timothy J. Walker ◽  
Cam Escoffery

There are many evidence-based interventions, cancer control practices, programs, treatments, and clinical practice guidelines across cancer control and prevention topic areas that have great potential for decreasing the cancer burden. Nevertheless, challenges in identifying evidence-based interventions (EBIs) that match the needs of community and practice settings, adapting EBIs for new populations and contexts, and implementing EBIs in real-world settings limit the public health impact of cancer control research and its products. This chapter provides an introduction to existing EBIs for cancer control and provides examples of different types of EBIs across the cancer continuum. It highlights issues related to the identification of EBIs, including the evaluation of EBI resources. It also describes processes that can be used to enhance the development, adaptation, and implementation of evidence-based cancer control interventions.


2020 ◽  
Vol 135 (6) ◽  
pp. 813-822
Author(s):  
Elizabeth Neilson ◽  
Jennifer Villani ◽  
Shawna L. Mercer ◽  
David L. Tilley ◽  
Isaah Vincent ◽  
...  

Objectives The Community Preventive Services Task Force (CPSTF) makes evidence-based recommendations about preventive services, programs, and policies in community settings to improve public health. CPSTF recommendations are based on systematic evidence reviews. This study examined the sponsors (ie, sources of financial, material, or intellectual support) for publications included in systematic reviews used by the CPSTF to make recommendations during a 9-year period. Methods We examined systematic evidence reviews (effectiveness reviews and economic reviews) for CPSTF findings issued from January 1, 2010, through December 31, 2018. We assessed study publications used in these reviews for sources of support; we classified sources as government, nonprofit, industry, or no identified support. We also identified country of origin for each sponsor and the most frequently mentioned sponsors. Results The CPSTF issued findings based on 144 systematic reviews (106 effectiveness reviews and 38 economic reviews). These reviews included 3846 publications: 3363 publications in effectiveness reviews and 483 publications in economic reviews. Government agencies supported 57.1% (n = 1919) of publications in effectiveness reviews and 59.2% (n = 286) in economic reviews. More than 1500 study sponsors from 36 countries provided support. The National Institutes of Health was the leading sponsor for effectiveness reviews (21.3%; 718 of 3363) and economic reviews (16.2%; 78 of 480), followed by the Centers for Disease Control and Prevention (7.0%; 234 of 3363 effectiveness reviews and 14.8%; 71 of 480 economic reviews). Conclusions The evidence base used by the CPSTF was supported by an array of sponsors, with government agencies providing the most support. Study findings highlight the need for sponsorship transparency and the role of government as a leading supporter of studies that underpin CPSTF recommendations for improving public health.


2016 ◽  
Vol 26 (suppl_1) ◽  
Author(s):  
A Månsdotter ◽  
K Godoy ◽  
K Guldbrandsson ◽  
R Henriksson ◽  
S Löfdahl ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 45-58
Author(s):  
Teresa Scassa

This article surveys the rise of contact tracing technologies during the COVID-19 pandemic and some of the privacy, ethical, and human rights issues they raise. It examines the relationship of these technologies to local public health initiatives, and how the privacy debate over these apps made the technology in some cases less responsive to public health agency needs. The article suggests that as countries enter the return to normal phase, the more important and more invasive contact tracing and disease surveillance technologies will be deployed at the local level in the context of employment, transit, retail services, and other activities. The smart city may be co-opted for COVID-19 surveillance, and individuals will experience tracking and monitoring as they go to work, shop, dine, and commute. The author questions whether the attention given to national contact tracing apps has overshadowed more local contexts where privacy, ethical, and human rights issues remain deeply important but relatively unexamined. This raises issues for city local governance and urban e-planning.


Sign in / Sign up

Export Citation Format

Share Document